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Purpose: Single nucleotide polymorphisms (SNPs) rs1048661 (p.R141L) and rs3825942 (p.G153D) in the lysyl oxidase-
like 1 (LOXL1) gene have been previously reported to be associated with pseudoexfoliation glaucoma (PEXG) in various
Asian and European populations, but these SNPs have not yet been studied in the Pakistani population. Therefore the aim
of the present study was to investigate the association of these two coding LOXL1 SNPs in Pakistani PEXG patients.
Methods: One hundred twenty-eight Pakistani patients diagnosed with PEXG and 180 healthy controls were recruited
for the study. Genomic DNA was extracted and both SNPs were genotyped by direct sequencing. Association of genotype
and allele frequencies with PEXG were analyzed using the Chi-square (χ2) test.
Results: Genotype and allele frequencies of both rs1048661 and rs3825942 were found to be significantly associated with
PEXG. The GG genotypes of both LOXL1 SNPs were associated with an increased risk of developing PEXG. In addition
the G alleles of rs1048661 and rs3825942 confer an increased risk for PEXG with an odds ratio (OR) of 2.98 (95% CI
1.94–4.57) and OR 6.83 (95% CI 2.94–16.67), respectively.
Conclusions: A significant association was found for the G allele of rs1048661 and rs3825942 in PEXG patients of
Pakistani origin.
Pseudoexfoliative  glaucoma  (PEXG)  occurs  when
pigment and abnormal basement membrane material from the
anterior segment of the eye deposit in the trabecular meshwork
(TM), which raises the intraocular pressure of the eye causing
a degeneration of the optic nerve. In addition the presence of
pseudoexfoliative  material  causes  changes  in  the  cornea,
camerular angle, lens and zonules as well as a significant loss
in the number of axons [1,2]. The accumulation of exfoliative
material in the juxtacanalicular tissue (JCT) results in the
disorganization of the JCT and Schlemm’s canal followed by
dysfunction  of  endothelial  cells,  which  appear  to  be  the
causative factor in the development of PEXG [3].
The  precise  etiology  and  pathogenesis  of
pseudoexfoliative glaucoma still remains unknown. Previous
molecular,  biochemical  and  immunohistochemical  studies
have  elucidated  that  proteins  of  the  extracellular  matrix
(ECM),  metabolism  and  cellular  stress  are  differentially
expressed in tissues of PEXG patients. It has been observed
that  the  pathophysiology  of  PEXG  involves  an  excessive
production of elastic microfibrillar components, changes in
the enzymatic cross linking processes, a proteolytic imbalance
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between matrix metalloproteinases and their inhibitors. It is
also  conceivable  that  lack  of  antioxidants  and  increased
cellular and oxidative stress may play an important role in the
progression  of  PEXG  as  a  stress-induced  elastic
microfibrillopathy  [4,5].  A  family  of  five  lysyl  oxidase
enzymes (LOX, LOXL1, LOXL2, LOXL3, and LOXL4) play
an important role in cross-linking between collagen, elastin
and fibrillin, which are the substrates of the LOXL1 enzymes
in the connective tissues. This cross-linking reaction provides
additional mechanical strength to the ECM and makes it more
resistant to degradation [6]. It has been reported in a recent
study that greater cross linking in the tissues of TM and ECM
makes the tissues stiffer in glaucomatous eyes as compared to
the  non-glaucomatous  eyes  [7].  LOXL1  expression  is
enhanced in the TM by the cytokine tumor growth factor beta1
(TGF β1). This changes the cross linking ability of LOXL1 in
PEXG, which results in the deposition of exfoliative material
and increased resistance in the aqueous outflow pathway [8].
A  recent  genome-wide  association  study  in  PEXG
patients  from  Iceland  and  Sweden  identified  a  strong
association  with  two  non-synonymous  polymorphisms  in
LOXL1 [9]. Similarly in German and Italian populations a
strong association has been observed between PEXG and
polymorphisms in LOXL1, which support an important role
of this gene in the progression of PEXG in various populations
[10]. In a meta-analysis of LOXL1 polymorphisms in different
populations  including  Caucasian,  Japanese,  Indian,  and
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1040Chinese it has been observed that the G allele of rs3825942 is
a common disease associated allele, with an overall odds ratio
of  10.89  (95%  CI  7.20–16.45).  However,  only  in  the
Caucasians case the G allele of rs1048661 was found to impart
an  increased  risk  to  the  disease  (OR  2.35)  while  in  the
Japanese population the G allele was found to have a highly
protective  role  (OR  0.03).  In  the  Chinese  and  Indian
populations  this  polymorphism  was  not  found  to  be
significantly associated with PEXG [11].
Although  single  nucleotide  polymorphisms  (SNPs)  in
LOXL1 have been studied in many populations, an analysis of
PEXG patients from Pakistan had not yet been performed.
Therefore the aim of the present study was to analyze the two
non-synonymous  polymorphisms  (rs1048661  and
rs3825942) in LOXL1 in PEXG patients from Pakistan.
METHODS
Patients: The present case control study included 128 patients
diagnosed with PEXG and 180 healthy controls of Pakistani
origin  who  were  recruited  from  the  Al-Shifa  Eye  Trust
Hospital  in  Rawalpindi,  Pakistan.  Complete  ophthalmic
examinations were performed for both patients and controls
as reported previously [12]. Briefly, clinical evaluation of
patients  included  measurement  of  cup-to-disk  ratio,  intra-
ocular pressure and slit lamp biomicroscopy to detect the
presence  of  exfoliative  material.  PEXG  was  diagnosed  in
patients who presented with an accumulation of microfibrillar
deposits or exfoliative material on the papillary ruff, a clear
annular zone, or flakes of exfoliative material with a grayish
central  disc  on  the  anterior  lens  capsule,  iris,  or  corneal
endothelium in one or both eyes. Controls and cases were
matched for age, gender and ethnicity (Punjabi).
Genomic  DNA  and  genotyping:  The  current  study  was
approved by the institutional review board of the Al-Shifa Eye
Trust  Hospital,  Rawalpindi,  Pakistan,  and  adhered  to  the
tenants of the Declaration of Helsinki. Whole blood samples
of both patients and controls were drawn by venipuncture after
obtaining informed written consent. The blood samples were
collected  in  EDTA  vacutainer  tubes  (Becton  Dickinson,
Franklin Lakes, NJ) and stored at 4 °C till further processing.
Genomic DNA was obtained from the whole blood using a
standard phenol chloroform method [13].
Genomic DNA was genotyped for two non-synonymous
SNPs located in exon 1 of LOXL1: rs1048661 (c.758G>T;
p.Arg141Leu)  and  rs3825942  (c.794G>A;  p.Gly153Asp).
The following primers were used to amplify a 259 bp product,
which spans both the polymorphic sites in exon 1 of LOXL1:
forward primer 5′-ATT CGG CTT TGG CCA GGT GC-3′ and
reverse primer 5′ GTA CAC GAA ACC CTG GTC GT-3′.
The polymerase chain reaction (PCR) mixture contained 2.5U
Taq  polymerase  (Roche,  Mannheim,  Germany),  1×  PCR
buffer, 1.5 mM MgCl2, 10 µM each primer and 50 ng genomic
DNA.  PCR  amplification  was  performed  with  an  initial
denaturation at 95 °C for 5 min, followed by 35 cycles of
denaturation at 95 °C for 45 s, primer annealing at 65 °C for
45 s, extension at 72 °C for 45 s, followed by a final extension
for 7 min at 72 °C. PCR products were separated on a 2%
agarose  gel  and  purified  using  PCR  clean-up  purification
plates  (NucleoFast®  96  PCR;  Macherey-Nagel,  Duren,
Germany), according to the manufacturer’s protocol. Purified
PCR products were analyzed by Sanger sequencing using an
automated DNA sequencer (Big Dye Terminator chemistry,
version 3 on a 3730 DNA analyzer; Applied Biosystems, Inc.,
Foster City, CA).
Statistical  analysis:  Data  were  analyzed  using  the  SPSS
statistical package (SPSS version 16.0; SPSS, Chicago, IL).
Odds  ratios  (OR)  for  genotype  and  allele  frequencies  of
patients compared to controls were calculated using the Chi-
square (χ2) test, taking a 95% confidence interval (95% CI)
into account. A p-value <0.05 was considered as statistically
significant.
RESULTS
All PEXG patients and control individuals originated from the
Punjab province of Pakistan. The PEXG patients had a mean
age of 47.3±10.3 years and included 54% males and 46%
females, whereas the controls had a mean age of 45.2±10.8
years with 52% males and 48% females.
The  distribution  of  the  LOXL1  genotype  and  allele
frequencies of SNPs rs1048661 and rs3825942 were analyzed
in PEXG patients and control individuals. Figure 1 shows the
normal, heterozygous and homozygous variant sequences for
the  two  SNPs  studied.  The  genotype  frequencies  were
consistent with the Hardy–Weinberg equilibrium (HWE) for
both SNPs in the controls. Table 1 gives the detailed count of
the  genotype  and  allele  frequencies  of  rs1048661  and
rs3825942  polymorphisms  of  LOXL1.  For  both  SNPs  a
significant association was identified for the genotype (p-
value  <0.001)  and  allele  frequencies  (p-value  <0.001)  in
PEXG  patients  as  compared  to  controls.  The  G  allele  of
rs1048661 was found in 85.2% of the patient alleles compared
to 65.8% of control alleles, demonstrating that it confers an
increased risk for PEXG (OR 2.98 [95% CI 1.94–4.57]). The
G allele of rs3825942 had an even stronger association with
PEXG, as it was found in 97.3% of patient alleles compared
to 83.9% of control alleles (OR 6.83 [95% CI 2.94–16.67]).
DISCUSSION
SNPs in LOXL1 have previously been associated with PEXG
in various European and Asian populations, to date these have
not been studied in the Pakistani population. The current study
is the first to demonstrate that LOXL1 SNPs are associated
with PEXG patients from Pakistan. The highest association
was observed with the G allele of rs3825942 (OR 6.83), which
was present in an overwhelming majority of the cases with
PEXG. A significant but lower association was also noted
with the G allele of rs1048661 (OR 2.98).
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1041A recent meta analysis of several studies from different
populations demonstrated a strong association between PEXG
and the G allele of SNP rs3825942 in Caucasian and Asian
populations (overall OR 10.89), while the G allele of SNP
rs1048661 was found to confer an increased risk in only the
Caucasian populations (OR 2.35), whereas in the Japanese
population it has a protective role (OR 0.03). This suggests
that  rs1048661  is  not  directly  implicated  in  the  disease
etiology of PEXG. It is more likely that rs3825942 is the
common  disease-associated  polymorphism  and  may  have
functional impacts on the LOXL1 protein [11]. This is in line
with our findings in the Pakistani population as we found a
higher OR (6.83) for rs3825942 as compared to rs1048661
(2.98). Similar results were obtained in recent studies of Latin
American and Uygur populations, which were not included in
the meta analysis of LOXL1 polymorphisms [14,15].
Not surprisingly our results differ from those reported in
the  Indian  population;  the  G-allele  of  the  rs1048661
polymorphism was found less frequently in Indian cases and
controls (allele frequencies of 72.1% and 63.4%, respectively)
and was not found to be significantly associated with PEXG
[16]. The allele frequencies in our Pakistani cases and controls
(85.2% and 65.8%, respectively) resembled more closely the
frequencies in American and European cohorts, rather than
Figure 1. Sequence chromatograms of
the two LOXL1 SNPs of Exon 1. A-C:
The  corresponding  normal  (GG),
heterozygous  (GT),  and  homozygous
variant (TT) sequences for rs1048661.
D-F: Normal (GG), heterozygous (GA),
and  homozygous  variant  (AA)
sequences for rs3825942.
TABLE 1. LOXL1 SNPS GENOTYPE AND ALLELE FREQUENCIES IN PEXG PATIENTS AND CONTROLS.
rs1048661 G/T Controls n=180 (%) PEXG n=128 (%) p-value p-value OR (95% CI)
GG 78 (43.3) 91 (71.1)                                       
GT 81 (45.0) 36 (28.1) 0.00000064 0.0001 2.63 (1.55–4.45)
TT 21 (11.7) 1 (0.80) 0.00001 24.50 (3.37–500)
Alleles
G 237 (65.8) 218 (85.2)                       0.0000001                       2.98 (1.94–4.57)
T 123 (34.2) 38 (14.8)
rs3825942 G/A Controls n=180 (%) PEXG n=128 (%) p-value p-value OR (95% CI)
GG 130 (72.2) 121 (94.5)                                       
GA 42 (23.3) 7 (5.50) 0.000003 0.00001 5.58 (2.30–14.19)
AA 8 (4.5) 0 (0.00) 0.007 (N/A)
Alleles
G 302 (83.90) 249 (97.3)                        0.0000001                     6.83 (2.94–16.67)
A 58 (16.10) 7 (2.70)
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1042the  Indian  population,  which  is  in  agreement  with  our
population genetics data where we see a cline passing through
Pakistan and diminishing in intensity toward India [17-19].
The frequency of the G-allele of rs3825942 in Indian patients
and  controls  (92.3%  and  74.2%,  respectively)  was  also
somewhat  lower  than  in  our  Pakistani  cohorts  (97.5%  in
PEXG and 83.9% in controls), and the OR was slightly lower
in the Indian cohort (4.17) compared to our Pakistani cohort
(6.98). The lower association of rs3825842 in the Indian and
Pakistani populations compared to other populations from
America, Europe and Asia (overall OR 10.89), suggests that
additional genetic factors may play a role in PEXG in India
and Pakistan, either within the LOXL1 or in other genes. This
is  supported  by  a  recent  study  demonstrating  that  neither
rs1048661 (R141L) nor rs3825942 (G153D) affect the amine
oxidase activity of LOXL1, suggesting that other unknown
genetic  factors  or  molecular  mechanisms  may  be  more
relevant to the development of PEXG [20].
In  previous  studies  we  have  identified  significant
associations  with  polymorphisms  in  the  glutathione  S-
transferase (GSTT1 and GSTM1) [21] and tumor necrosis
factor alpha (TNF-α) [12] with PEXG. Among these higher
OR was observed for TNF-α (8.37) as compared to LOXL1
(6.98), GSTT1 (4.26), and GSTM1 (3.81), the combined effect
of all these genes probably have a significant contribution in
causing PEXG in the Pakistani cohort. The present study
confirms  the  involvement  of  the  two  LOXL1  coding
polymorphisms in PEXG in the Pakistani population. Further
studies at the functional level are required to better understand
the  involvement  of  LOXL1,  glutathione  S-transferase  and
tumor necrosis factor alpha in PEXG, which could potentially
aid the development of therapeutic approaches for the disease.
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